CogRx

0 followers

‌

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders.

Employees

11-50

Links


Org chart

Collapse
Gilbert M. Rishton
Co-Founder and Chief Chemist
John Doyle
Chief Financial Officer
Anthony O. Caggiano
Chief Medical Officer And Head Of R&d
Anthony Caggiano
Chief Medical Officer and Head of R&D
Mary Hamby
VP, Research
Theresa Devins
Vice President Clinical Operations

Board & advisors

Michael Grundman
Medical Advisor
Kaj Blennow
Medical Advisor
Steven DeKosky
Medical Advisor
Larry Ereshefsky
Medical Advisor
John Harrison
Medical Advisor
Mary Sano
Medical Advisor
Philip Scheltens
Medical Advisor
Henrik Zetterberg
Medical Advisor
John Cirrito
Scientific Advisor
Michael Cahill
Scientific Advisor
Rolf Craven
Scientific Advisor
Alison M. Goate
Scientific Advisor
Cynthia A. Lemere
Scientific Advisor
Harry LeVine III
Scientific Advisor
Robert H. Mach
Scientific Advisor
Tara L. Spires-Jones
Scientific Advisor